Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Teva Pharmaceutical Industries has launched the authorized generic version of Provigil (modafinil) and initiated the shipment of the product.
Subscribe to our email newsletter
Cephalon, a wholly owned subsidiary of Teva Pharmaceutical Industries, will market the product.
Provigil will continue to be manufactured under the brand product’s NDA at the same facility where it is currently produced, the company said.
The brand product had annual sales of approximately $1.1bn in the US, according to IMS sales data.